Adjuvant Therapy in Muscle-Invasive Bladder Cancer and Upper Tract Urothelial Carcinoma - 10/04/18
Doi : 10.1016/j.ucl.2017.12.010
Tala Achkar, MD a, Rahul A. Parikh, MD, PhD b, ⁎ 
a Department of Medicine, Division of Hematology-Oncology, University of Pittsburgh Medical Center, 5150 Centre Avenue, Pittsburgh, PA 15232, USA
b Department of Medicine, Division of Medical Oncology, University of Kansas Medical Center, 2330 Shawnee Mission Parkway, Suite 210, MS 5003, Westwood, KS 66205, USA
∗Corresponding author.
Riassunto |
This article summarizes the role of adjuvant chemotherapy in muscle-invasive and transitional cell carcinoma of the bladder and upper urinary tract.
Il testo completo di questo articolo è disponibile in PDF.Keywords : Muscle-invasive bladder cancer (MIBC), Adjuvant chemotherapy, Neoadjuvant chemotherapy, Urothelial cancer, Micrometastases
Mappa
| Conflicts of Interest: The authors have nothing to disclose. |
© 2018
Elsevier Inc. Tutti i diritti riservati.
Vol 45 - N° 2
P. 257-266 - Maggio 2018 Ritorno al numero
Articolo precedente
- Quality of Life After Radical Cystectomy
- Mark D. Tyson, Daniel A. Barocas
- Endoscopic Approaches to Upper Tract Urothelial Carcinoma
- Firas G. Petros, Roger Li, Surena F. Matin
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?